Skip to main content

Can Infertility Be Cured? What Reverses, What Is Managed, and What Does Not Come Back (2026)

IVF Education · November 17, 2026
ProIVF Medical Editorial Team · ProIVF Medical Advisory Board reviewed
can infertility be curedcan infertility be reversedinfertility treatment optionsprevent infertilityinfertility causes
Can Infertility Be Cured? What Reverses, What Is Managed, and What Does Not Come Back (2026)

Infertility is curable in the sense that matters to most couples - a live birth - far more often than it is reversible at the level of the underlying disease. Roughly 85% of couples have an identifiable cause, and each cause has a different ceiling.

This article was prepared by the ProIVF medical editorial team from the peer-reviewed trials, Cochrane reviews and guideline pages cited throughout, and reviewed by the ProIVF Medical Advisory Board. Numbers are reported with the metric used by the original authors, because odds ratios, risk ratios and absolute rates are not interchangeable.

What does “cured” mean when the goal is a baby?

Two different questions hide inside “can infertility be cured”. The first is whether the disease process can be reversed - a blocked tube reopened, ovulation restored, a varicocele repaired.

The second is whether the couple ends up with a child, which assisted reproduction can deliver even when the first answer is no.

The World Health Organization defines infertility as failure to achieve a pregnancy after 12 months or more of regular unprotected intercourse, and notes that some causes are preventable while others are not (WHO infertility fact sheet, updated 28 November 2025). It also estimates that about one in six people of reproductive age worldwide experience infertility in their lifetime. That framing matters: a condition affecting that many people is mostly managed, not erased.

How often is a cause even found?

About 85% of infertile couples have an identifiable cause, and the remaining 15% are labelled unexplained infertility (JAMA review, 2021). The same review puts ovulatory disorders at roughly 25% of diagnoses, with about 70% of anovulatory women having polycystic ovary syndrome.

That leaves 15% of couples in a category where there is no lesion to fix at all. For them the honest answer to “can it be cured” is that there is nothing identified to cure, but treatment can still produce a pregnancy - a distinction that changes what a couple should expect from each appointment.

Which causes respond to treatment?

The table below lists the main causes and the highest-quality effect estimate available for each, using the metric the original authors reported.

CauseReversible or manageable?Key evidence
Ovulation disorders / PCOSUsually reversible with medicationLetrozole vs clomiphene: live birth OR 1.72 (95% CI 1.40-2.11), NNTB 10, high certainty (Cochrane 2022)
Tubal blockage / hydrosalpinxSurgery or bypass with IVFSalpingectomy vs no surgery: clinical pregnancy RR 2.02 (1.44-2.82), 19% rising to 27-52% (Cochrane 2020)
EndometriosisSurgery helps, does not cureLaparoscopic treatment vs diagnostic laparoscopy: viable intrauterine pregnancy OR 1.89 (1.25-2.86), 3 RCTs, 528 women (Cochrane 2020)
Uterine polypsRemoved, benefit depends on pathwayPolypectomy raised clinical pregnancy in IUI cycles; no clear benefit in IVF, 8 studies, 2,267 patients (review 2019)
Male factor / varicocelePartly reversible, partly bypassed by ICSIVaricocele repair: live birth OR 1.70 in oligospermia, pregnancy OR 2.34 in azoospermia, 7 studies, 1,241 men (Fertil Steril 2016)
Age-related ovarian declineNot reversible6-cycle cumulative live birth 86% under 35 vs 42% at 40+ (optimistic assumptions) (NEJM 2009)

The absolute numbers behind that table matter more than the odds ratios, because odds ratios exaggerate when events are common.

Ovulation disorders and PCOS

Restoring ovulation is the most reliable reversal in reproductive medicine. The 2022 Cochrane review pooled 41 randomised trials and 6,522 women with anovulatory PCOS and found that letrozole produced higher live birth rates than clomiphene or tamoxifen, with an OR of 1.72 and a number needed to treat of 10 for one additional live birth.

In absolute terms, a woman with a 20% chance of live birth on clomiphene would have a 27% to 35% chance on letrozole, and ovarian hyperstimulation syndrome stayed at 0.5% in both arms with high-certainty evidence. What that means clinically is that a substantial share of anovulatory infertility resolves without ever reaching IVF - but only if ovulation is actually tracked and the dose is adjusted. Our guide to PCOS and IVF covers what happens when ovulation induction alone does not work.

Tubal disease and hydrosalpinx

A damaged tube is a mechanical problem, and the evidence is unusually clear about which mechanical fix helps. In the Cochrane review of tubal surgery, removing a hydrosalpinx before IVF doubled the chance of clinical pregnancy compared with leaving it in place, with a risk ratio of 2.02 and clinical pregnancy rising from 19% to the 27-52% range.

Reconstructive tubal surgery is still offered in selected cases, but the same review found salpingectomy outperformed expectant management, and IVF bypasses the tube entirely. For couples weighing the two routes, the honest comparison is cost, recovery time and the number of cycles each path needs - not “which one cures the tube”. Tubal factor infertility and IVF sets out that decision in detail.

Endometriosis

Surgery for endometriosis improves pregnancy rates, but the effect size is moderate and the evidence quality is mixed. Across three randomised trials including 528 women, laparoscopic treatment produced a viable intrauterine pregnancy odds ratio of 1.89 (95% CI 1.25-2.86) compared with diagnostic laparoscopy alone, rated moderate-quality evidence.

Pain relief is a separate question with weaker data, and the review could not confirm a difference between ablation and excision. That is why surgery is usually framed as one step rather than a cure, and why endometriosis and IVF often runs in parallel rather than after it.

Uterine polyps and fibroids

Removing a polyp is a small procedure, and the benefit depends on how the couple is trying to conceive. A systematic review of eight studies and 2,267 patients found that hysteroscopic resection of polyps under 2 cm increased clinical pregnancy in women having intrauterine insemination, while no clear benefit was seen for clinical pregnancy, live birth, miscarriage or implantation in women going straight to IVF.

Fibroids sit on much shakier ground. Evidence that removing them restores fertility is far weaker than for polyps, so the decision usually turns on size, position and whether the fibroid distorts the cavity: submucosal fibroids that bulge into the cavity are the ones most often offered hysteroscopic resection, while intramural and subserosal fibroids are more often left alone before IVF.

That asymmetry is worth remembering when a clinic proposes a “clean-up” hysteroscopy before a first IVF cycle. It is a reasonable step in some scenarios, but the trial evidence does not support presenting it as a cure for the infertility itself.

Male factor and azoospermia

Male factors contribute to about half of infertile couples, and part of that is genuinely reversible. A meta-analysis of seven studies and 1,241 men found that varicocele repair raised live birth in oligospermic men with an OR of 1.70, raised pregnancy in azoospermic men with an OR of 2.34, and increased sperm retrieval after repair with an OR of 2.51.

For men with no sperm in the ejaculate, the ceiling is different: micro-TESE retrieves sperm in about 47% of procedures (95% CI 45-49%), and the cumulative live birth per cycle is about 24%. Our male infertility and IVF guide covers the full pathway, including why a three-month lead time is needed for any lifestyle change to reach the ejaculate.

What cannot be reversed?

Age-related decline in ovarian reserve is the one factor no treatment reverses. That sentence is not pessimism; it is the conclusion the authors of the largest cumulative live birth analysis reached themselves.

“Our results indicate that IVF may largely overcome infertility in younger women, but it does not reverse the age-dependent decline in fertility.” - Malizia, Hacker and Penzias, New England Journal of Medicine, 2009

The numbers behind that quote come from 6,164 patients and 14,248 cycles: across six cycles, cumulative live birth reached 86% for women under 35 and 42% for women aged 40 or older under optimistic assumptions, falling to 65% and 23% under conservative assumptions that count women who dropped out as failures. Our IVF success rates by age page shows the per-cycle version of the same curve.

Other categories that are managed rather than cured include primary ovarian insufficiency, congenital absence of the uterus or gonads, and most genetic causes of azoospermia. In these situations egg donation, sperm donation, surrogacy or adoption are the routes to parenthood - different treatments, not cures.

Does treating always beat waiting?

No, and unexplained infertility is where that becomes visible. A network meta-analysis of 27 randomised trials and 4,349 couples compared expectant management, ovarian stimulation, IUI, stimulated IUI and IVF, and found insufficient evidence that any of them beat expectant management in the whole group (Cochrane 2019).

The same analysis found the picture reverses in couples with a poor natural prognosis, where stimulated IUI (OR 4.48, 95% CI 2.00-10.1) and IVF or ICSI (OR 4.99, 95% CI 2.07-12.04) both outperformed waiting, with moderate-certainty evidence. Treatment also raised multiple pregnancy risk from a 0.6% baseline to as much as 5.4%. Unexplained infertility covers how prognosis is estimated in practice.

Can infertility be prevented?

Some of it can, and the WHO fact sheet says so explicitly: infections, smoking, obesity and environmental exposures account for a meaningful share of cases. Untreated sexually transmitted infections are a leading cause of tubal damage, which is why the same tube problem that needs surgery in one couple is preventable in another.

The part that cannot be prevented is the biological clock, and no supplement changes the follicle count. That is why fertility preservation exists as a separate decision made before the decline, not as a rescue afterwards.

What do these numbers mean for your next step?

They mean the order of testing matters more than the label on the diagnosis. A couple with anovulation should not start with IVF, and a couple with bilateral hydrosalpinges should not spend three cycles on ovulation induction.

A practical sequence is: confirm the diagnosis with two semen analyses, tubal assessment and ovarian reserve testing; treat what is reversible; then choose the assisted route that matches the remaining barrier. Our IVF cost guide is worth reading before that last step, because the number of cycles needed changes the total far more than the price of a single cycle.

Three couples, three definitions of success

The three accounts below are composite patient experiences prepared for illustration. They are not individual medical records, and identifying details have been changed.

Amara, 31, London. She had irregular cycles for nine years and had been told she would “probably need IVF”. Her workup showed anovulatory PCOS with a normal tube study and a normal semen analysis. She took letrozole for four cycles at about GBP 30 per cycle, ovulated in three of them, and conceived in the fourth. “The expensive part was the year I spent believing the problem was my age, when nobody had checked whether I was ovulating at all.”

Dana and Piotr, 38 and 41, Toronto. A hydrosalpinx on the left side was found on HSG after 18 months of trying. Their clinic offered either laparoscopic salpingectomy followed by IVF, or IVF with the tube left in place. They chose surgery, paid about CAD 4,200 out of pocket for it, and started IVF seven weeks later; the first transfer produced a live birth. “We were told the tube could not be repaired, and that turned out to be the useful part of the conversation.”

Wei, 36, Shanghai. Her AMH was 0.6 ng/mL and her husband’s semen analysis was normal. Two IVF cycles produced one euploid embryo each time; the first transfer did not implant and the second ended in a miscarriage at 8 weeks. Their third option was donor eggs abroad, and they decided to stop treatment instead. “Nothing was fixable. What helped was a doctor who said that out loud instead of selling me a fourth cycle.”

FAQ

Q: Can infertility be cured completely?

For some causes, yes at the level of the disease: ovulation can be restored with letrozole (live birth OR 1.72 versus clomiphene), a hydrosalpinx can be removed (clinical pregnancy RR 2.02), and a varicocele can be repaired (live birth OR 1.70). For age-related ovarian decline and primary ovarian insufficiency, no treatment reverses the underlying process, and the goal shifts to achieving a pregnancy with the eggs or embryos available.

Q: What percentage of infertility cases have no explanation?

About 15% of couples are diagnosed with unexplained infertility after a complete workup, according to a 2021 JAMA review, while roughly 85% have an identifiable cause. Even in the unexplained group, treatment is not futile: in couples with a poor natural prognosis, stimulated IUI raised live birth with an OR of 4.48 and IVF or ICSI with an OR of 4.99 compared with waiting.

Q: Does IVF cure infertility?

IVF bypasses the barrier rather than curing it. Across six cycles, cumulative live birth reached 86% for women under 35 and 42% for women aged 40 or older under optimistic assumptions, falling to 65% and 23% under conservative ones.

Those figures describe what treatment can achieve, not a reversal of the diagnosis.

Q: Can infertility be reversed naturally?

Lifestyle changes can move individual parameters: weight loss, stopping smoking and treating infection all improve the odds, and surgery repairs some anatomical causes. Nothing reverses ovarian reserve - in the six-cycle analysis above, women aged 40 or older still reached only 42% cumulative live birth under optimistic assumptions and 23% under conservative ones.

Q: Is blocked fallopian tube curable?

It depends on the type and location of the blockage. Removing a hydrosalpinx before IVF doubled clinical pregnancy in randomised trials (RR 2.02, 19% rising to 27-52%), and catheter-guided recanalisation helps selected proximal blocks.

When the tube cannot be reconstructed, IVF bypasses it entirely, which is why the tube itself does not have to be “cured” to have a child.

Q: How long should we try before treatment?

The standard threshold is 12 months of regular unprotected intercourse, or 6 months if the woman is 35 or older, and immediately if there is a known cause such as absent periods, prior tubal surgery or abnormal semen parameters (ACOG, treating infertility). Earlier assessment is also justified when cycles are very irregular, because ovulation disorders are the most treatable group.

Q: Does treating male factor improve IVF outcomes?

Sometimes. Varicocele repair raised live birth in oligospermic men (OR 1.70) and sperm retrieval after repair (OR 2.51) in a meta-analysis of 1,241 men, but the benefit depends on the type of male factor; for azoospermia, micro-TESE retrieves sperm in about 47% of procedures, which is a different question from improving sperm quality.

Planning the next step

If you are at the start of a workup, ask for the five baseline tests before agreeing to any treatment plan: two semen analyses, a tubal assessment, ovarian reserve testing, ovulation confirmation and a uterine cavity assessment. That list is what separates a reversible cause from a manageable one.

If you are deciding between surgery and assisted reproduction, compare them on total cost and total cycles rather than on the elegance of the procedure. And if a clinician tells you a cause cannot be reversed, ask what the expected live birth rate is with the remaining options - that number is the one that matters for planning.

This article is for general information and does not replace an individual consultation. Studies cited above link to their PubMed records or to the WHO and ACOG pages referenced in the text; figures used as clinical convention and the amounts inside the patient cases are illustrative and are not individually sourced. Our hospital directory lists centres by country and success-rate reporting, and the editorial team can point you to the relevant national guidance on request.

Ready to start your fertility journey?

Get a personalized plan from our medical advisors